Colchicine for pericarditis: hype or hope?

Colchicine has been effectively used in the treatment of several inflammatory conditions, such as gouty attacks, serositis related to familial Mediterranean fever, Behçet syndrome, and more recently also in acute and recurrent pericarditis. Growing evidence has shown that the drug may be useful to treat an acute attack and may be a way to cope with the prevention of pericarditis in acute and recurrent cases and after cardiac surgery. Nevertheless, clinicians are often sceptical about the efficacy of the drug, and concerns have risen on possible side effects and tolerability. In this review, we analyse current evidence to support the use of the drug, as well as possible harms and risks related to drug interactions, reaching the conclusion that colchicine is safe and useful in recurrent pericarditis, if specific precautions are followed, although less evidence supports its use for the treatment of acute pericarditis, where colchicine remains optional and there is a need for further multicentre confirmatory studies. This paper also reviews specific dosing and precautions for the clinical use.

[1]  Y. Adler,et al.  Diagnosis and management of pericardial diseases , 2009, Nature Reviews Cardiology.

[2]  L. Coda,et al.  Rationale and design of the COPPS trial: a randomised, placebo-controlled, multicentre study on the use of colchicine for the primary prevention of postpericardiotomy syndrome , 2007, Journal of cardiovascular medicine.

[3]  W. Robertson,et al.  Deaths from intravenous colchicine resulting from a compounding pharmacy error--Oregon and Washington, 2007. , 2007, MMWR. Morbidity and mortality weekly report.

[4]  L. Espinoza,et al.  Rapid onset of muscle weakness (rhabdomyolysis) associated with the combined use of simvastatin and colchicine. , 2007, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[5]  M. Imazio,et al.  CORP (COlchicine for Recurrent Pericarditis) and CORP-2 trials – two randomized placebo-controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale , 2007, Journal of cardiovascular medicine.

[6]  Y. Adler,et al.  Prognosis of idiopathic recurrent pericarditis as determined from previously published reports. , 2007, The American journal of cardiology.

[7]  M. Imazio,et al.  Treatment of refractory recurrent pericarditis. , 2007, Journal of cardiovascular medicine.

[8]  M. Imazio,et al.  Investigation on Colchicine for Acute Pericarditis: a multicenter randomized placebo-controlled trial evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of pericarditis; study design amd rationale , 2007, Journal of cardiovascular medicine.

[9]  C. Fuller,et al.  Fatal toxic myopathy attributed to propofol, methylprednisolone, and cyclosporine after prior exposure to colchicine and simvastatin , 2007, Clinical Rheumatology.

[10]  U. Yasar,et al.  Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever. , 2007, The Journal of rheumatology.

[11]  R. Shabetai,et al.  Pathogenesis, management, and prevention of recurrent pericarditis , 2007, Journal of cardiovascular medicine.

[12]  N. Sethi,et al.  Colchicine and HMG Co-A reductase inhibitors induced myopathy-a case report. , 2006, Neurotoxicology.

[13]  A. Topeli,et al.  Rhabdomyolysis in a Patient Treated with Colchicine and Atorvastatin , 2006, The Annals of pharmacotherapy.

[14]  B. Jortner.  The return of the dark neuron. A histological artifact complicating contemporary neurotoxicologic evaluation. , 2006, Neurotoxicology.

[15]  Y. Adler,et al.  Letter regarding article by Imazio et al, "colchicine in addition to conventional therapy for acute pericarditis". , 2006, Circulation.

[16]  Y. Adler,et al.  Colchicine for recurrent acute pericarditis. , 2006, Archives of internal medicine.

[17]  G. Melli,et al.  Rhabdomyolysis: An Evaluation of 475 Hospitalized Patients , 2005, Medicine.

[18]  M. Imazio,et al.  Colchicine in Addition to Conventional Therapy for Acute Pericarditis: Results of the COlchicine for acute PEricarditis (COPE) Trial , 2005, Circulation.

[19]  M. Imazio,et al.  Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. , 2005, Archives of internal medicine.

[20]  M. Imazio,et al.  Management, risk factors, and outcomes in recurrent pericarditis. , 2005, The American journal of cardiology.

[21]  V. Cheng,et al.  Two Probable Cases of Serious Drug Interaction Between Clarithromycin and Colchicine , 2005, Southern medical journal.

[22]  C K Yeung,et al.  Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  E. Solmazgul,et al.  Possible colchicine rhabdomyolysis in a fluvastatin-treated patient , 2005, The Annals of pharmacotherapy.

[24]  G. Alaylı,et al.  Acute Myopathy in a Patient with Concomitant Use of Pravastatin and Colchicine , 2005, The Annals of pharmacotherapy.

[25]  E. Schwammenthal,et al.  Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent pericarditis: a multi-centre all-case analysis. , 2005, European heart journal.

[26]  L. Chauvelot‐Moachon,et al.  Acute Colchicine Intoxication During Clarithromycin Administration , 2004, The Annals of pharmacotherapy.

[27]  M. Tarnopolsky,et al.  Cytoskeletal myotoxicity from simvastatin and colchicine , 2004, Muscle & nerve.

[28]  J. Soler‐Soler,et al.  Relapsing pericarditis , 2004, Heart.

[29]  M. Pras,et al.  Intravenous colchicine for treatment of patients with familial Mediterranean fever unresponsive to oral colchicine. , 2003, The Journal of rheumatology.

[30]  E. Ben-Chetrit,et al.  Reproductive system in familial Mediterranean fever: an overview , 2003, Annals of the rheumatic diseases.

[31]  J. Pascussi,et al.  Colchicine down-regulates cytochrome P450 2B6, 2C8, 2C9, and 3A4 in human hepatocytes by affecting their glucocorticoid receptor-mediated regulation. , 2003, Molecular pharmacology.

[32]  H. Chiu,et al.  Colchicine-induced acute myopathy in a patient with concomitant use of simvastatin. , 2002, Clinical neuropharmacology.

[33]  Y. Molad.  Update on colchicine and its mechanism of action , 2002, Current rheumatology reports.

[34]  C. Schumann,et al.  Current aspects of colchicine therapy -- classical indications and new therapeutic uses. , 2001, European journal of medical research.

[35]  P. Routledge,et al.  Colchicine induced rhabdomyolysis , 2001, Postgraduate medical journal.

[36]  R. Moorman.  A DECADE OF EXPERIENCE , 2000 .

[37]  A. Bayés‐Genís,et al.  Colchicine treatment for recurrent pericarditis. A decade of experience. , 1998, Circulation.

[38]  H. Takikawa,et al.  Effects of colchicine and phenothiazine on biliary excretion of organic anions in rats , 1998, Journal of gastroenterology and hepatology.

[39]  A. Bayés‐Genís,et al.  Colchicine for large pericardial effusion , 1998, Clinical cardiology.

[40]  R. Vm,et al.  [Colchicine treatment for recurrent pericarditis]. , 1997, Anales de medicina interna.

[41]  P. Souček,et al.  Colchicine biotransformation by human liver microsomes. Identification of CYP3A4 as the major isoform responsible for colchicine demethylation. , 1997, Biochemical pharmacology.

[42]  Y. Adler,et al.  Usefulness of colchicine in preventing recurrences of pericarditis. , 1994, The American journal of cardiology.

[43]  B. Kommerell,et al.  Plasma kinetics and biliary excretion of colchicine in patients with chronic liver disease after oral administration of a single dose and after long-term treatment. , 1994, Scandinavian journal of gastroenterology.

[44]  J. Leighton,et al.  Colchicine clearance is impaired in alcoholic cirrhosis , 1991, Hepatology.

[45]  D. Zemer,et al.  Long-term colchicine treatment in children with familial Mediterranean fever. , 1991, Arthritis and rheumatism.

[46]  M. Spino,et al.  Colchicine: A State‐of‐the‐Art Review , 1991, Pharmacotherapy.

[47]  A. Millaire,et al.  Treatment of acute or recurrent pericarditis with colchicine. , 1991, Circulation.

[48]  E. Ben-Chetrit,et al.  Colchicine prophylaxis in familial Mediterranean fever: reappraisal after 15 years. , 1991, Seminars in arthritis and rheumatism.

[49]  A. Bayés de Luna,et al.  Recurrent pericarditis. Relief with colchicine. , 1990, Circulation.

[50]  Rieger Eh,et al.  Colchicine neuromyopathy after renal transplantation. , 1990 .

[51]  H. Henning,et al.  Is myopathy in renal transplant patients induced by cyclosporin or colchicine? , 1990, The Lancet.

[52]  A. D. Luna,et al.  COLCHICINE FOR RECURRENT PERICARDITIS , 1987, The Lancet.

[53]  J. Kirwan,et al.  Prolonged reduction in polymorphonuclear adhesion following oral colchicine. , 1981, Annals of the rheumatic diseases.

[54]  Y. Adler,et al.  Therapy for recurrent acute pericarditis: a rheumatological solution? , 2006, Clinical and experimental rheumatology.

[55]  E. Niel,et al.  Colchicine today. , 2006, Joint, bone, spine : revue du rhumatisme.

[56]  M. Yacoub,et al.  [Guidelines on the diagnosis and management of pericardial diseases. Executive summary]. , 2004, Revista espanola de cardiologia.

[57]  J. Scherrmann,et al.  Pharmacokinetics and absolute bioavailability of colchicine after i. v. and oral administration in healthy human volunteers and elderly subjects , 2004, European Journal of Clinical Pharmacology.

[58]  P. De Groote,et al.  Treatment of recurrent pericarditis with colchicine. , 1994, European heart journal.

[59]  N. Halasz,et al.  Colchicine neuromyopathy after renal transplantation. , 1990, Transplantation.

[60]  M. Hurtig,et al.  Operative Arthroscopy in the Treatment of Bilateral Stifle Osteochondritis Dissecans in a Dog , 1989, Veterinary and Comparative Orthopaedics and Traumatology.

[61]  R. Menta,et al.  Reversible acute cyclosporin nephrotoxicity induced by colchicine administration. , 1987, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.